CONTECI Program: A New Way to Control Peripheral Arterial Disease Using New Technologies
- Conditions
- Personal SatisfactionTelemedicinePeripheral Arterial Disease
- Registration Number
- NCT02762916
- Lead Sponsor
- Consorci Sanitari del Maresme
- Brief Summary
The current increase in chronic diseases calls for changes to the health system. It is necessary to promote expert patient in chronic disease. The expansion of new technologies gives us new tools to face new challenges, providing efficiency, expertise and autonomy. The characteristics of peripheral arterial disease make possible to promote expert patient and the self-management. In order to bring these concepts together the telemedicine program was created to promote expert patient for increasing the quality of life and satisfaction of patients and improving the efficiency of the health system.
Methods: Randomized clinical trial on patients with peripheral arterial disease in intermittent claudication grade. They were randomized into two groups: intervention arm (IA) using CONTECI program for self-managing and control arm (CA), followed as usual vascular visits.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
- Patient with confirmed PAD
- Over 18 years old
- Informed Consent
- Internet Access (patient or family)
- Spanish or Catalan fluidity
- Cognitive impairment
- Previous patency arterial surgery
- Sever chronic obstructive pulmonary disease (GOLD III/ IV)
- Patients with decreased survival of 12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method satisfaction. Analogical scale 0-100. To compare the satisfaction in the new model control and the model before 12 months
- Secondary Outcome Measures
Name Time Method Health resources consumption: rate of Emergency visits, scheduled visits, extra visits, Mail per participant 6 and 12 months Clinical features. Pateint who turned to grade 3 or 4 of Le Fontaine classification, number of surgeries. 6 and 12 months PAD grade 3 and 4, surgeries
Quality of life. EuroQol5D were used. Change from baseline Quality of line at 12 months. 12 months